Skip to main content
Signal8

Parks Diane L.

SEC insider (Form 3/4/5 filer). CIK 0001781026. Director at SOLIGENIX, INC. (SNGX) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in PRINCETON, NJ.

Companies Parks Diane L. has filed insider reports for

  • SOLIGENIX, INC. (SNGX): Director
  • Kura Oncology, Inc. (KURA): Director
  • Celularity Inc (CELU): Director
Parks Diane L. profile photo

Parks Diane L.

CIK: 0001781026

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)6 (37.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

SOLIGENIX, INC. logo
SNGX

SOLIGENIX, INC.

Director
Kura Oncology, Inc. logo
KURA

Kura Oncology, Inc.

Director
Celularity Inc logo
CELU

Celularity Inc

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • SOLIGENIX, INC. logo
    SNGX

    SOLIGENIX, INC.

    Oct 12, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    56 shares-
  • SOLIGENIX, INC. logo
    SNGX

    SOLIGENIX, INC.

    Oct 12, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    121 shares-
  • SOLIGENIX, INC. logo
    SNGX

    SOLIGENIX, INC.

    Oct 12, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    6 shares-
  • SOLIGENIX, INC. logo
    SNGX

    SOLIGENIX, INC.

    Oct 12, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    128 shares-
  • SOLIGENIX, INC. logo
    SNGX

    SOLIGENIX, INC.

    Oct 12, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    63 shares-
  • SOLIGENIX, INC. logo
    SNGX

    SOLIGENIX, INC.

    Oct 12, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    192 shares-
  • SOLIGENIX, INC. logo
    SNGX

    SOLIGENIX, INC.

    Sep 17, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    78.9K shares-
  • Kura Oncology, Inc. logo
    KURA

    Kura Oncology, Inc.

    Jun 4, 2026
    Award

    Option to purchase common stock

    Direct
    35K shares-
  • Celularity Inc logo
    CELU

    Celularity Inc

    Jan 12, 2026
    Award
    Direct
    30K shares-
  • Celularity Inc logo
    CELU

    Celularity Inc

    Dec 29, 2025
    Award
    Direct
    125K shares-

1-10 of 16